BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Animas Corporation's OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA (JOBS)


7/1/2008 7:55:46 AM

WEST CHESTER, Pa., July 1 /PRNewswire/ -- Animas Corporation announced today the clearance of its OneTouch(R) Ping(TM) Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. "People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier."

OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch(R) Ultra(R) Test Strips.

OneTouch Ping also offers the following:

-- Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 12 feet for 24 hours and has a color screen for outstanding pump readability

-- Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs

-- Proven blood glucose monitoring technology - the meter-remote utilizes OneTouch Ultra Test Strips, the leading brand of test strips covered by more health plans at the lowest co-pay

ezManager(R) MAX Diabetes Management Software

The OneTouch Ping system will also work with the recently cleared ezManager(R) MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter- remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager(R) MAX software is MAC and PC compatible.

OneTouch Ping will be available for shipment in mid-August 2008. Customers can order at any time by calling 1-877-937-7867 or visit www.animascorp.com

About Animas Corporation

As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, Inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.

To learn more about Animas and its products, visit www.animascorp.com.

About LifeScan, Inc.

LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products in the U.S., is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers. Every day, more than 4.5 million people with diabetes rely on OneTouch(R) Brand Products to provide accurate glucose results and help them use this information to take action so they can stay healthy.

For healthcare professional resources, and information on diabetes care and LifeScan products and services, visit www.LifeScan.com.

CONTACT: Melissa Katz, Corporate Communications, +1-484-356-1844, Mobile:
+1-215-514-0957

Web site: http://www.animascorp.com/
http://www.LifeScan.com/


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->